Advertisement
American Journal of Kidney Diseases

Anorexia Nervosa and the Kidney

      Anorexia nervosa is a common psychiatric disorder that disproportionately affects adolescents and young adults and is associated with high rates of morbidity and mortality. Anorexia nervosa can affect the kidney in numerous ways, including increased rates of acute kidney injury and chronic kidney disease, electrolyte abnormalities, and nephrolithiasis. Additionally, the diagnosis and treatment of anorexia nervosa–associated kidney diseases are challenging, reflecting complications such as refeeding syndrome, as well as the limitations of serum creatinine level in this population to estimate kidney function and the psychosocial challenges inherent with treating systemic manifestations of psychiatric conditions. In this review, we discuss kidney diseases and kidney-associated conditions that occur in individuals with anorexia nervosa, summarizing many of the challenges in treating patients with this disease.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sullivan P.F.
        Mortality in anorexia nervosa.
        Am J Psychiatry. 1995; 152: 1073-1074
        • Sullivan P.F.
        Cause and outcome of anorexia nervosa and bulimia nervos.
        in: Fairburn C.G. Brownell K.B. Eating Disorders and Obesity A Comprehensive Handbook. 2nd ed. The Guildford Press, New York, NY2002: 226-233
        • Steinhausen H.C.
        The outcome of anorexia nervosa in the 20th century.
        Am J Psychiatry. 2002; 159: 1284-1293
        • Treasure J.
        • Claudino A.M.
        • Zucker N.
        Eating disorders.
        Lancet. 2010; 375: 583-593
        • Palla B.
        • Litt I.F.
        Medical complications of eating disorders in adolescents.
        Pediatrics. 1988; 81: 613-623
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        4th ed. text revision. Amercian Psychiatric Association, Washington, DC1994
        • Mehler P.S.
        Eating disorders: 2.
        Hosp Pract (Minneap). 1996; 31 (120, 123, passim): 107-114
        • Hoek H.W.
        • van H.D.
        Review of the prevalence and incidence of eating disorders.
        Int J Eat Disord. 2003; 34: 383-396
        • Hudson J.I.
        • Hiripi E.
        • Pope Jr, H.G.
        • Kessler R.C.
        The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.
        Biol Psychiatry. 2007; 61: 348-358
        • Deter H.C.
        • Herzog W.
        Anorexia nervosa in a long-term perspective: results of the Heidelberg-Mannheim Study.
        Psychosom Med. 1994; 56: 20-27
        • Zipfel S.
        • Lowe B.
        • Reas D.L.
        • Deter H.C.
        • Herzog W.
        Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study.
        Lancet. 2000; 355: 721-722
        • Deter H.C.
        • Schellberg D.
        • Kopp W.
        • Friederich H.C.
        • Herzog W.
        Predictability of a favorable outcome in anorexia nervosa.
        Eur Psychiatry. 2005; 20: 165-172
        • Herzog D.B.
        • Field A.E.
        • Keller M.B.
        • et al.
        Subtyping eating disorders: is it justified?.
        J Am Acad Child Adolesc Psychiatry. 1996; 35: 928-936
        • Umeki S.
        Biochemical abnormalities of the serum in anorexia nervosa.
        J Nerv Ment Dis. 1988; 176: 503-506
        • Riemenschneider T.
        • Bohle A.
        Morphologic aspects of low-potassium and low-sodium nephropathy.
        Clin Nephrol. 1983; 19: 271-279
        • Cremer W.
        • Bock K.D.
        Symptoms and course of chronic hypokalemic nephropathy in man.
        Clin Nephrol. 1977; 7: 112-119
        • Brotman A.W.
        • Stern T.A.
        • Brotman D.L.
        Renal disease and dysfunction in two patients with anorexia nervosa.
        J Clin Psychiatry. 1986; 47: 433-434
        • Schneiter S.
        • Berwert L.
        • Bonny O.
        • Teta D.
        • Burnier M.
        • Vogt B.
        [Anorexia nervosa and the kidney].
        Rev Med Suisse. 2009; 5: 440-444
        • Luthra M.
        • Davids M.R.
        • Shafiee M.A.
        • Halperin M.L.
        Anorexia nervosa and chronic renal insufficiency: a prescription for disaster.
        Qjm. 2004; 97: 167-178
        • Miller K.K.
        • Grinspoon S.K.
        • Ciampa J.
        • Hier J.
        • Herzog D.
        • Klibanski A.
        Medical findings in outpatients with anorexia nervosa.
        Arch Intern Med. 2005; 165: 561-566
        • Mars D.R.
        • Anderson N.H.
        • Riggall F.C.
        Anorexia nervosa: a disorder with severe acid-base derangements.
        South Med J. 1982; 75: 1038-1042
        • Arimura Y.
        • Tanaka H.
        • Yoshida T.
        • et al.
        Anorexia nervosa: an important cause of chronic tubulointerstitial nephropathy.
        Nephrol Dial Transplant. 1999; 14: 957-959
        • Abdel-Rahman E.M.
        • Moorthy A.V.
        End-stage renal disease (ESRD) in patients with eating disorders.
        Clin Nephrol. 1997; 47: 106-111
        • Torres V.E.
        • Young Jr, W.F.
        • Offord K.P.
        • Hattery R.R.
        Association of hypokalemia, aldosteronism, and renal cysts.
        N Engl J Med. 1990; 322: 345-351
        • Reungjui S.
        • Roncal C.A.
        • Sato W.
        • et al.
        Hypokalemic nephropathy is associated with impaired angiogenesis.
        J Am Soc Nephrol. 2008; 19: 125-134
        • Sharp C.W.
        • Freeman C.P.
        The medical complications of anorexia nervosa.
        Br J Psychiatry. 1993; 162: 452-462
        • Delanaye P.
        • Krzesinski J.M.
        Nouveautés à propos du métabolisme du phosphore.
        Rev Med Liege. 2005; 60: 189-197
        • Hall R.C.
        • Beresford T.P.
        Medical complications of anorexia and bulimia.
        Psychiatr Med. 1989; 7: 165-192
        • Estour B.
        • Germain N.
        • Diconne E.
        • et al.
        Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa.
        J Clin Endocrinol Metab. 2010; 95: 2203-2210
        • American Psychiatric Association
        Treatment of patients with eating disorders, third edition.
        Am J Psychiatry. 2006; 163(7): 4-54
        • Menahem S.A.
        • Perry G.J.
        • Dowling J.
        • Thomson N.M.
        Hypokalaemia-induced acute renal failure.
        Nephrol Dial Transplant. 1999; 14: 2216-2218
        • Herzog W.
        • Deter H.C.
        • Fiehn W.
        • Petzold E.
        Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study.
        Psychol Med. 1997; 27: 269-279
        • Jonat L.M.
        • Birmingham C.L.
        Kidney stones in anorexia nervosa: a case report and review of the literature.
        Eat Weight Disord. 2003; 8: 332-335
        • Fuentebella J.
        • Kerner J.A.
        Refeeding syndrome.
        Pediatr Clin North Am. 2009; 56: 1201-1210
        • Mehler P.S.
        • Winkelman A.B.
        • Andersen D.M.
        • Gaudiani J.L.
        Nutritional rehabilitation: practical guidelines for refeeding the anorectic patient.
        J Nutr Metab. 2010; (2010. pii:625782)
        • Levey A.S.
        • de Jong P.E.
        • Coresh J.
        • et al.
        The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
        Kidney Int. 2011; 80: 17-28
        • Stevens L.A.
        • Coresh J.
        • Greene T.
        • Levey A.S.
        Assessing kidney function—measured and estimated glomerular filtration rate.
        N Engl J Med. 2006; 354: 2473-2483
        • Stevens L.A.
        • Levey A.S.
        Measured GFR as a confirmatory test for estimated GFR.
        J Am Soc Nephrol. 2009; 20: 2305-2313
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • Delanaye P.
        • Cohen E.P.
        Formula-based estimates of the GFR: equations variable and uncertain.
        Nephron Clin Pract. 2008; 110: c48-c53
        • de Jong P.E.
        • Brenner B.M.
        From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria.
        Kidney Int. 2004; 66: 2109-2118
        • van der Velde
        • Matsushita K.
        • Coresh J.
        • et al.
        Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.
        Kidney Int. 2011; 79: 1341-1352
        • Astor B.C.
        • Matsushita K.
        • Gansevoort R.T.
        • et al.
        Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease.
        Kidney Int. 2011; 79: 1331-1340
        • Gansevoort R.T.
        • Matsushita K.
        • van dV.
        • et al.
        Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes.
        Kidney Int. 2011; 80: 93-104
        • National Kidney Foundation
        K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification.
        Am J Kidney Dis. 2002; 39(2): S1-S266
        • Delanaye P.
        • Mariat C.
        • Krzesinski J.M.
        • Cavalier E.
        Paricalcitol for reduction of albuminuria in diabetes.
        Lancet. 2011; 377: 635
        • Durand E.
        • Prigent A.
        The basics of renal imaging and function studies.
        Q J Nucl Med. 2002; 46: 249-267
        • Skluzacek P.A.
        • Szewc R.G.
        • Nolan III, C.R.
        • Riley D.J.
        • Lee S.
        • Pergola P.E.
        Prediction of GFR in liver transplant candidates.
        Am J Kidney Dis. 2003; 42: 1169-1176
        • Delanaye P.
        • Radermecker R.P.
        • Rorive M.
        • Depas G.
        • Krzesinski J.M.
        Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example.
        Nephrol Dial Transplant. 2005; 20: 2024-2028
        • Delanaye P.
        • Mariat C.
        • Cavalier E.
        • Krzesinski J.M.
        Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum.
        Nephrol Dial Transplant. 2009; 24: 3593-3596
        • Delanaye P.
        • Krzesinski J.M.
        Indexing of renal function parameters by body surface area: intelligence or folly?.
        Nephron Clin Pract. 2011; 119: c289-c292
        • Perrone R.D.
        • Madias N.E.
        • Levey A.S.
        Serum creatinine as an index of renal function: new insights into old concepts.
        Clin Chem. 1992; 38: 1933-1953
        • Bauer J.H.
        • Brooks C.S.
        • Burch R.N.
        Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate.
        Am J Kidney Dis. 1982; 2: 337-346
        • Shemesh O.
        • Golbetz H.
        • Kriss J.P.
        • Myers B.D.
        Limitations of creatinine as a filtration marker in glomerulopathic patients.
        Kidney Int. 1985; 28: 830-838
        • Morgan D.B.
        • Dillon S.
        • Payne R.B.
        The assessment of glomerular function: creatinine clearance or plasma creatinine?.
        Postgrad Med J. 1978; 54: 302-310
        • Toto R.D.
        • Kirk K.A.
        • Coresh J.
        • et al.
        Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
        J Am Soc Nephrol. 1997; 8: 279-287
        • Levey A.S.
        • Bosch J.P.
        • Lewis J.B.
        • Greene T.
        • Rogers N.
        • Roth D.
        A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.
        Ann Intern Med. 1999; 130: 461-470
        • Cockcroft D.W.
        • Gault M.H.
        Prediction of creatinine clearance from serum creatinine.
        Nephron. 1976; 16: 31-41
        • Delanaye P.
        • Cavalier E.
        • Radermecker R.P.
        • et al.
        Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa.
        Nephron Clin Pract. 2008; 110: c158-c163
        • Delanaye P.
        • Cavalier E.
        • Radermecker R.P.
        • et al.
        Estimation of GFR by different creatinine- and cystatin-C-based equations in anorexia nervosa.
        Clin Nephrol. 2009; 71: 482-491
        • Froissart M.
        • Rossert J.
        • Jacquot C.
        • Paillard M.
        • Houillier P.
        Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function.
        J Am Soc Nephrol. 2005; 16: 763-773
        • Poggio E.D.
        • Nef P.C.
        • Wang X.
        • et al.
        Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease equations in estimating GFR in ill hospitalized patients.
        Am J Kidney Dis. 2005; 46: 242-252
        • Brion L.P.
        • Boeck M.A.
        • Gauthier B.
        • Nussbaum M.P.
        • Schwartz G.J.
        Estimation of glomerular filtration rate in anorectic adolescents.
        Pediatr Nephrol. 1989; 3: 16-21
        • Fabbian F.
        • Pala M.
        • Scanelli G.
        • Manzato E.
        • Longhini C.
        • Portaluppi F.
        Estimation of renal function in patients with eating disorders.
        Int J Eat Disord. 2011; 44: 233-237
        • Seronie-Vivien S.
        • Delanaye P.
        • Pieroni L.
        • Mariat C.
        • Froissart M.
        • Cristol J.P.
        Cystatin C: current position and future prospects.
        Clin Chem Lab Med. 2008; 46: 1664-1686
        • Macdonald J.
        • Marcora S.
        • Jibani M.
        • et al.
        GFR estimation using cystatin C is not independent of body composition.
        Am J Kidney Dis. 2006; 48: 712-719